LAB
Standard Biotools Inc
NASDAQ: LAB · HEALTHCARE · MEDICAL DEVICES
$0.93
+4.69% today
Updated 2026-04-30
Market cap
$350.48M
P/E ratio
—
P/S ratio
4.11x
EPS (TTM)
$-0.15
Dividend yield
—
52W range
$1 – $2
Volume
2.7M
Standard Biotools Inc (LAB) Earnings
Quarterly earnings history, analyst estimates, and stock price reaction.
EPS beat streak
3 of 8
Last 8 quarters
Avg EPS surprise
+60.0%
Last 4 quarters
Revenue YoY growth
-93.1%
Most recent quarter
EPS YoY growth
+236.0%
Most recent quarter
Earnings surprise history (last 12 quarters)
Beat estimate Missed estimate
Quarterly EPS and revenue trend
Quarterly revenue EPS (diluted)
How the stock reacts to earnings
Avg 1-day reaction
-2.7%
Last 2 reports
Positive reaction rate
50%
1 of 2 quarters
Largest single-day move
-8.1%
2025-11-04
| Report date | EPS actual | Surprise | Close before | Close after | 1-day reaction |
|---|---|---|---|---|---|
| 2026-02-18 | $0.07 | +226.1% | $1.12 | $1.15 | +2.7% |
| 2025-11-04 | $-0.09 | -80.0% | $1.24 | $1.14 | -8.1% |
Quarterly earnings history
| Fiscal quarter ending | EPS estimate | EPS actual | Surprise | Revenue | YoY revenue |
|---|---|---|---|---|---|
| 2025-12-31 | $-0.05 | $0.07 | +226.1% | $3.22M | -93.1% |
| 2025-09-30 | $-0.05 | $-0.09 | -80.0% | $19.55M | -56.5% |
| 2025-06-30 | $-0.07 | $-0.03 | +60.1% | $21.76M | -3.2% |
| 2025-03-31 | $-0.04 | $-0.05 | -19.5% | $40.80M | -10.4% |
| 2024-12-31 | $-0.03 | $-0.05 | -64.7% | $46.72M | +65.7% |
| 2024-09-30 | $-0.09 | $-0.07 | +22.2% | $44.97M | +77.3% |
| 2024-06-30 | $-0.08 | $-0.12 | -50.0% | $22.49M | -18.7% |
| 2024-03-31 | $-0.12 | $-0.27 | -125.0% | $45.54M | +81.3% |
| 2023-12-31 | $-0.13 | $-0.25 | -92.3% | $28.19M | — |
| 2023-09-30 | $-0.12 | $-0.27 | -125.0% | $25.37M | — |
| 2023-06-30 | $-0.21 | $-0.22 | -4.8% | $27.67M | — |
| 2023-03-31 | $-0.06 | $-0.11 | -98.9% | $25.12M | — |
Frequently asked questions
Has Standard Biotools Inc beaten earnings estimates?
Standard Biotools Inc has beaten Wall Street EPS estimates in 3 of its last 8 quarterly reports, with an average EPS surprise of +60.0% over the last 3 quarters.
How does LAB stock react to earnings?
LAB stock has moved an average of -2.7% in the trading day following earnings over its last 2 reports, with positive reactions in 50% of those quarters.
What is Standard Biotools Inc's revenue growth rate?
Standard Biotools Inc reported year-over-year revenue growth of -93.1% in its most recent quarter, with EPS growing +236.0% year-over-year.